New Delhi, May 7 () Pharma major Biocon Tuesday said the company retains economic interest in global commercialisation of Hulio in-licensed by Mylan.
Biocon retains economic interest in Hulio’s global commercialisation
More from Industry NewsMore posts in Industry News »
- Aurobindo, Unichem recall products in US market
- After recommending booster dose for 40+, INSACOG says more experiments needed
- Omicron scare: Experts advise booster doses for health workers
- BioNTech CEO confident of quickly adapting vaccine for Omicron
- Double vaccinate against Covid first, experts say amid calls for booster shots